6P9F

Crystal structure of RAR-related orphan receptor C (NHIS-RORGT(244-487)-L6-SRC1(678-692)) in complex with a phenyl (3-phenylpyrrolidin-3-yl)sulfone inhibitor


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.8 Å
  • R-Value Free: 0.223 
  • R-Value Work: 0.184 

wwPDB Validation 3D Report Full Report


This is version 1.0 of the entry. See complete history

Literature

Identification of potent, selective and orally bioavailable phenyl ((R)-3-phenylpyrrolidin-3-yl)sulfone analogues as ROR gamma t inverse agonists.

Lu, Z.Duan, J.J.Xiao, H.Neels, J.Wu, D.R.Weigelt, C.A.Sack, J.S.Khan, J.Ruzanov, M.An, Y.Yarde, M.Karmakar, A.Vishwakrishnan, S.Baratam, V.Shankarappa, H.Vanteru, S.Babu, V.Basha, M.Kumar Gupta, A.Kumaravel, S.Mathur, A.Zhao, Q.Salter-Cid, L.M.Carter, P.H.Murali Dhar, T.G.

(2019) Bioorg.Med.Chem.Lett. --: --

  • DOI: 10.1016/j.bmcl.2019.06.036

  • PubMed Abstract: 
  • An X-ray crystal structure of one of our previously discovered RORγt inverse agonists bound to the RORγt ligand binding domain revealed that the cyclohexane carboxylic acid group of compound 2 plays a significant role in RORγt binding, forming four h ...

    An X-ray crystal structure of one of our previously discovered RORγt inverse agonists bound to the RORγt ligand binding domain revealed that the cyclohexane carboxylic acid group of compound 2 plays a significant role in RORγt binding, forming four hydrogen bonding and ionic interactions with RORγt. SAR studies centered around the cyclohexane carboxylic acid group led to identification of several structurally diverse and more potent compounds, including new carboxylic acid analogues 7 and 20, and cyclic sulfone analogues 34 and 37. Notably, compounds 7 and 20 were found to maintain the desirable pharmacokinetic profile of 2.


    Organizational Affiliation

    Research and Development, Bristol-Myers Squibb Company, Princeton, NJ 08543-4000, United States.,Research and Development, Bristol-Myers Squibb Company, Princeton, NJ 08543-4000, United States. Electronic address: james.duan@bms.com.,Research and Development, Bristol-Myers Squibb Company, Princeton, NJ 08543-4000, United States. Electronic address: zhonghui.lu@bms.com.,Bristol-Myers Squibb-Biocon Research Center, Bangalore, India.




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
Nuclear receptor ROR-gamma, Nuclear receptor coactivator 1 chimera
A, B
285Homo sapiensMutation(s): 0 
Gene Names: RORC (NR1F3, RORG, RZRG), NCOA1 (BHLHE74, SRC1)
EC: 2.3.1.48
Find proteins for P51449 (Homo sapiens)
Go to Gene View: RORC
Go to UniProtKB:  P51449
Find proteins for Q15788 (Homo sapiens)
Go to Gene View: NCOA1
Go to UniProtKB:  Q15788
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
O5A
Query on O5A

Download SDF File 
Download CCD File 
A, B
trans-4-{(3R)-3-[(4-fluorophenyl)sulfonyl]-3-[4-(1,1,1,2,3,3,3-heptafluoropropan-2-yl)phenyl]pyrrolidine-1-carbonyl}cyclohexane-1-carboxylic acid
C27 H25 F8 N O5 S
AVHWMAVUUHFRKE-UAVUOLJFSA-N
 Ligand Interaction
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.8 Å
  • R-Value Free: 0.223 
  • R-Value Work: 0.184 
  • Space Group: P 41
Unit Cell:
Length (Å)Angle (°)
a = 64.128α = 90.00
b = 64.128β = 90.00
c = 159.666γ = 90.00
Software Package:
Software NamePurpose
Aimlessdata scaling
BUSTERrefinement
XDSdata reduction

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History 

Deposition Data

  • Deposited Date: 2019-06-10 
  • Released Date: 2019-07-17 
  • Deposition Author(s): Sack, J.

Revision History 

  • Version 1.0: 2019-07-17
    Type: Initial release